07:57 AM EDT, 10/29/2026 (MT Newswires) -- Finnish medical technology company Nexstim (NXTMH.HE) secured an order for its NBS 6 system from an undisclosed hospital in Finland, according to a Thursday release. The existing client will upgrade an earlier-generation Nexstim navigated transcranial magnetic stimulation system with the new platform, gaining access to step-by-step software guidance, smart targeting tools, and reusable head trackers. The hospital uses the brain stimulation technology to treat major depressive disorder and chronic neuropathic pain.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.